Short‐term impact (< 12 months) child fruit and vegetable intake · children aged 5 years and under
1 finding from 1 review
Cost‐effectiveness ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term impact (< 12 months) unintended adverse events ‐ not reported · children aged 5 years and under
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · depression and anxiety for people with dementia
1 finding from 1 review
Quality of life post‐treatment · depression and anxiety for people with dementia
1 finding from 1 review
Activities of daily living · depression and anxiety for people with dementia
1 finding from 1 review
Cognitive function · depression and anxiety for people with dementia
1 finding from 1 review
Neuropsychiatric symptoms · depression and anxiety for people with dementia
1 finding from 1 review
Depressive symptoms · depression and anxiety for people with dementia
1 finding from 1 review
Depression remission · depression and anxiety for people with dementia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression: < 50% reduction in scale scores at end of treatment (primary outcome) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes depression: < 50% reduction in scale scores at end of treatment… compared with placebo (very low certainty).
1 finding from 1 review
Depression: mean scores at end of treatment (secondary outcome) · people with depression after stroke
1 finding from 1 review
Adverse events: death ‐ at end of treatment (secondary outcome) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: death (secondary outcome) compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects (central nervous system) · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: all ‐ central nervous system events (e.g. confusion,… compared with placebo (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · people with depression after stroke
It is very uncertain whether pharmacological interventions changes adverse events: all ‐ gastrointestinal effects (e.g. constipation,… compared with placebo (very low certainty).
1 finding from 1 review
Health‐related quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
no estimate extracted
2778 participants
Low
Respiratory‐related hospital admissions · patients with chronic obstructive pulmonary disease
It is very uncertain whether self‐management interventions changes respiratory‐related hospital admissions compared with usual care (very low certainty).
OR 0.75 [0.57, 0.98]
3263 participants
Very low
Respiratory‐related mortality · patients with chronic obstructive pulmonary disease
Self‐management interventions showed no clear difference in respiratory‐related mortality compared with usual care (low certainty).
OR 1.7 [0.89, 3.26]
1572 participants
Low
All‐cause mortality · patients with chronic obstructive pulmonary disease
Self‐management interventions showed no clear difference in all‐cause mortality compared with usual care (low certainty).
OR 0.86 [0.59, 1.26]
5719 participants
Low
Hospital admissions · patients with chronic obstructive pulmonary disease
Self‐management interventions showed no clear difference in all‐cause hospital admissions compared with usual care (moderate certainty).
OR 0.88 [0.71, 1.08]
2633 participants
Moderate